PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment
Main Authors: | JA Roman Ivorra, M de la Rubia Navarro, I Canovas Olmos, R Gonzalez Mazario, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, C Najera Herranz, R Negueroles Albuixech, E Vicens Bernabeu, C Riesco Barcena, S Leal Rodríguez, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, J Oller Rodríguez, JR Ivorra Cortes, J Fragio Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-10-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients
by: JA Roman Ivorra, et al.
Published: (2022-10-01) -
P149 Clinical worsening in non-adherent belimumab treatment in SLE
by: José Ivorra Cortés, et al.
Published: (2024-03-01) -
PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus
by: JA Roman Ivorra, et al.
Published: (2022-10-01) -
P28 Drug-induced lupus: clinical and serological features in a tertiary hospital
by: José Ivorra Cortés, et al.
Published: (2024-03-01) -
P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients
by: José Ivorra Cortés, et al.
Published: (2024-03-01)